The review searched several research databases and considered clinical studies, other reviews, and selected laboratory or mechanistic studies. Across the human studies summarized, saliva production often fell during treatment, and some studies reported changes in saliva buffering, cavity-related measures, gum inflammation, bleeding, plaque, or probing depth. These changes were not consistent across all studies, and some appeared to be temporary.

The review did not establish that isotretinoin directly causes periodontitis, a severe form of gum disease. It also reported that available evidence does not support routinely delaying necessary dental procedures solely because someone is taking isotretinoin, while emphasizing that evidence specific to oral surgery is sparse. The review described this as an area requiring further study rather than a settled conclusion.